Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis
European Innovation CouncilHORIZON-EIC-ACC-BFID: 190119321
EC Contribution
€15,579
Consortium Size
1 orgs
Start Year
2023
▶Summary
OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on a medicinal cannabis extract. It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis (YCJ-01) and another for Leukodystrophies (YCJ-02), both are paediatric rare diseases. This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis (TS).